Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats

<p>Abstract</p> <p>Background</p> <p>The metabolic syndrome (MetS) is a cluster of metabolic abnormalities comprising visceral obesity, dyslipidaemia and insulin resistance (IR). With the onset of IR, the expression of lipoprotein lipase (LPL), a key regulator of lipopr...

Full description

Bibliographic Details
Main Authors: Ton So, Kadir Khalid, Liong Shih, Chia Yoke, Lim Wai, Syed Husain Sharifah
Format: Article
Language:English
Published: BMC 2009-07-01
Series:Lipids in Health and Disease
Online Access:http://www.lipidworld.com/content/8/1/31
_version_ 1818789417933864960
author Ton So
Kadir Khalid
Liong Shih
Chia Yoke
Lim Wai
Syed Husain Sharifah
author_facet Ton So
Kadir Khalid
Liong Shih
Chia Yoke
Lim Wai
Syed Husain Sharifah
author_sort Ton So
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The metabolic syndrome (MetS) is a cluster of metabolic abnormalities comprising visceral obesity, dyslipidaemia and insulin resistance (IR). With the onset of IR, the expression of lipoprotein lipase (LPL), a key regulator of lipoprotein metabolism, is reduced. Increased activation of glucocorticoid receptors results in MetS symptoms and is thus speculated to have a role in the pathophysiology of the MetS. Glycyrrhizic acid (GA), the bioactive constituent of licorice roots (<it>Glycyrrhiza glabra</it>) inhibits 11β-hydroxysteroid dehydrogenase type 1 that catalyzes the activation of glucocorticoids. Thus, oral administration of GA is postulated to ameliorate the MetS.</p> <p>Results</p> <p>In this study, daily oral administration of 50 mg/kg of GA for one week led to significant increase in LPL expression in the quadriceps femoris (<it>p </it>< 0.05) but non-significant increase in the abdominal muscle, kidney, liver, heart and the subcutaneous and visceral adipose tissues (<it>p </it>> 0.05) of the GA-treated rats compared to the control. Decrease in adipocyte size (<it>p </it>> 0.05) in both the visceral and subcutaneous adipose tissue depots accompanies such selective induction of LPL expression. Consistent improvement in serum lipid parameters was also observed, with decrease in serum free fatty acid, triacylglycerol, total cholesterol and LDL-cholesterol but elevated HDL-cholesterol (<it>p </it>> 0.05). Histological analysis using tissue lipid staining with Oil Red O showed significant decrease in lipid deposition in the abdominal muscle and quadriceps femoris (<it>p </it>< 0.05) but non-significant decrease in the heart, kidney and liver (<it>p </it>> 0.05).</p> <p>Conclusion</p> <p>Results from this study may imply that GA could counteract the development of visceral obesity and improve dyslipidaemia via selective induction of tissue LPL expression and a positive shift in serum lipid parameters respectively, and retard the development of IR associated with tissue steatosis.</p>
first_indexed 2024-12-18T14:39:14Z
format Article
id doaj.art-876d460a64d745feb28e506f6fde7c8b
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-12-18T14:39:14Z
publishDate 2009-07-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-876d460a64d745feb28e506f6fde7c8b2022-12-21T21:04:26ZengBMCLipids in Health and Disease1476-511X2009-07-01813110.1186/1476-511X-8-31Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated ratsTon SoKadir KhalidLiong ShihChia YokeLim WaiSyed Husain Sharifah<p>Abstract</p> <p>Background</p> <p>The metabolic syndrome (MetS) is a cluster of metabolic abnormalities comprising visceral obesity, dyslipidaemia and insulin resistance (IR). With the onset of IR, the expression of lipoprotein lipase (LPL), a key regulator of lipoprotein metabolism, is reduced. Increased activation of glucocorticoid receptors results in MetS symptoms and is thus speculated to have a role in the pathophysiology of the MetS. Glycyrrhizic acid (GA), the bioactive constituent of licorice roots (<it>Glycyrrhiza glabra</it>) inhibits 11β-hydroxysteroid dehydrogenase type 1 that catalyzes the activation of glucocorticoids. Thus, oral administration of GA is postulated to ameliorate the MetS.</p> <p>Results</p> <p>In this study, daily oral administration of 50 mg/kg of GA for one week led to significant increase in LPL expression in the quadriceps femoris (<it>p </it>< 0.05) but non-significant increase in the abdominal muscle, kidney, liver, heart and the subcutaneous and visceral adipose tissues (<it>p </it>> 0.05) of the GA-treated rats compared to the control. Decrease in adipocyte size (<it>p </it>> 0.05) in both the visceral and subcutaneous adipose tissue depots accompanies such selective induction of LPL expression. Consistent improvement in serum lipid parameters was also observed, with decrease in serum free fatty acid, triacylglycerol, total cholesterol and LDL-cholesterol but elevated HDL-cholesterol (<it>p </it>> 0.05). Histological analysis using tissue lipid staining with Oil Red O showed significant decrease in lipid deposition in the abdominal muscle and quadriceps femoris (<it>p </it>< 0.05) but non-significant decrease in the heart, kidney and liver (<it>p </it>> 0.05).</p> <p>Conclusion</p> <p>Results from this study may imply that GA could counteract the development of visceral obesity and improve dyslipidaemia via selective induction of tissue LPL expression and a positive shift in serum lipid parameters respectively, and retard the development of IR associated with tissue steatosis.</p>http://www.lipidworld.com/content/8/1/31
spellingShingle Ton So
Kadir Khalid
Liong Shih
Chia Yoke
Lim Wai
Syed Husain Sharifah
Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats
Lipids in Health and Disease
title Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats
title_full Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats
title_fullStr Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats
title_full_unstemmed Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats
title_short Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats
title_sort lipoprotein lipase expression serum lipid and tissue lipid deposition in orally administered glycyrrhizic acid treated rats
url http://www.lipidworld.com/content/8/1/31
work_keys_str_mv AT tonso lipoproteinlipaseexpressionserumlipidandtissuelipiddepositioninorallyadministeredglycyrrhizicacidtreatedrats
AT kadirkhalid lipoproteinlipaseexpressionserumlipidandtissuelipiddepositioninorallyadministeredglycyrrhizicacidtreatedrats
AT liongshih lipoproteinlipaseexpressionserumlipidandtissuelipiddepositioninorallyadministeredglycyrrhizicacidtreatedrats
AT chiayoke lipoproteinlipaseexpressionserumlipidandtissuelipiddepositioninorallyadministeredglycyrrhizicacidtreatedrats
AT limwai lipoproteinlipaseexpressionserumlipidandtissuelipiddepositioninorallyadministeredglycyrrhizicacidtreatedrats
AT syedhusainsharifah lipoproteinlipaseexpressionserumlipidandtissuelipiddepositioninorallyadministeredglycyrrhizicacidtreatedrats